U.S. Senators Susan Collins (R-ME) and Claire McCaskill (D-MO) wrote to several drug makers asking them to explain their pricing for decades-old drug Naloxone, the most common formulation used by police departments, hospitals, and addiction advocacy organizations, to reverse the effect of opioid and heroin overdoses. Read article here….
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.